US BANCORP \DE\ - APTEVO THERAPEUTICS INC ownership

APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L207. A total of 30 filers reported holding APTEVO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of APTEVO THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$010.0%0.00%
Q2 2022$010.0%0.00%
Q1 2022$010.0%0.00%
Q4 2021$010.0%0.00%
Q3 2021$010.0%0.00%
Q2 2021$010.0%0.00%
Q1 2021$010.0%0.00%
Q4 2020$01
-91.7%
0.00%
Q3 2020$0120.0%0.00%
Q2 2020$012
-20.0%
0.00%
Q1 2020$0150.00%
Other shareholders
APTEVO THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 1,334,169$440,2760.32%
ARMISTICE CAPITAL, LLC 1,235,000$407,5500.01%
Divergent Wealth Advisors 10,000$3,3000.00%
FIFTH THIRD BANCORP 291$960.00%
FRANKLIN RESOURCES INC 10,997$3,6290.00%
BANK OF AMERICA CORP /DE/ 6$20.00%
PNC FINANCIAL SERVICES GROUP, INC. 142$470.00%
WELLS FARGO & COMPANY/MN 1,562$5150.00%
NORTHERN TRUST CORP 14,121$4,6600.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of APTEVO THERAPEUTICS INC shareholders